Stock Events

Stock Events

First Tracks Biotherapeutics 

$34.50
5
+$0.36+1.07% 18:57 Today

Statistics

Day High
36.3
Day Low
33.99
52W High
49.91
52W Low
14.72
Volume
221,562,704
Avg. Volume
-
Mkt Cap
1.23B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Dec 2Expected
Q2 2026
Next
-0.95
-0.9
-0.85
-0.8
Expected EPS
-0.902742
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2025
0Revenue
-166.09MNet Income

Analyst Ratings

$66.27Average Price Target
The highest estimate is ⁦100.00⁩.
From 11 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TRAX. It's not an investment recommendation.
NVIDIA
2
NVDA
Schwab US Dividend Equity
2
SCHD
AMD
2
AMD
Johnson & Johnson
2
JNJ

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

First Tracks Biotherapeutics Inc is a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases. Its clinical-stage pipeline includes rosnilimab, a selective pathogenic T cell depleter, for which it completed a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA), ANB033, a CD122 antagonist, in a Phase 1b trial for celiac disease (CeD) and eosinophilic esophagitis (EoE), and ANB101, a BDCA2 modulator, in a Phase 1a trial. The company operates in one reportable segment focused on research and development activities to deliver immunology therapeutics for autoimmune and inflammatory diseases.
Show More
CEO
Daniel R. Faga
Employees
104
Country
United States
ISIN
US3371851029
WKN
000A428R1

Listings

MX
MX
TRAX.MX
XNAS
US
TRAX
F
DE
B43.F
MU
DE
B43.MU

0 Comments

Share your thoughts

FAQs

What is First Tracks Biotherapeutics stock price today?▼
The current price of TRAX is $34.50 USD — it has increased by +1.07% in the past 24 hours. Watch First Tracks Biotherapeutics stock price performance more closely on the chart.
What is First Tracks Biotherapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange First Tracks Biotherapeutics stocks are traded under the ticker TRAX.
What is First Tracks Biotherapeutics market cap?▼
Today First Tracks Biotherapeutics has the market capitalization of 1.23B
When is the next First Tracks Biotherapeutics earnings date?▼
First Tracks Biotherapeutics is going to release the next earnings report on December 2, 2026.
What were First Tracks Biotherapeutics earnings last quarter?▼
TRAX earnings for the last quarter are -0.95 USD per share, whereas the estimation was -0.8 USD resulting in a -18.37% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is First Tracks Biotherapeutics revenue for the last year?▼
First Tracks Biotherapeutics revenue for the last year amounts to 0 USD.
What is First Tracks Biotherapeutics net income for the last year?▼
TRAX net income for the last year is -166.09M USD.
How many employees does First Tracks Biotherapeutics have?▼
As of October 15, 2026, the company has 104 employees.
In which sector is First Tracks Biotherapeutics located?▼
First Tracks Biotherapeutics operates in the Health & Wellness sector.
When did First Tracks Biotherapeutics complete a stock split?▼
First Tracks Biotherapeutics has not had any recent stock splits.
Where is First Tracks Biotherapeutics headquartered?▼
First Tracks Biotherapeutics is headquartered in SAN DIEGO, United States.